From the Breakthroughs Blog: Congress
Spotlighting COVID-19 innovations for global needs on Capitol Hill
On November 19, GHTC hosted a virtual roundtable with four organizations advancing COVID-19 innovations and 12 staff members from congressional offices. The dialogue focused on the need for COVID-19 innovations designed for use in low-resource settings and the role the US Agency for International Development (USAID) could play in supporting this effort. Read on for a recap of the event.
GHTC’s response to COVID-19
The COVID-19 pandemic is a global health crisis affecting populations around the world. GHTC is tracking and responding to the pandemic through US and multilateral efforts.
A year in review: The global health innovation stories that shaped 2019
As the year comes to a close, we are taking a look back at the top global health innovation stories and news that shaped 2019.
GHTC brings a global perspective to the Rally for Medical Research
A crisp chill hung in the air one early morning last week as members of the GHTC team stepped up the stairs adjoining the newly refurbished Apple Carnegie Library in Washington, DC, to pose for a photo with more than one hundred fellow research and development (R&D) advocates from across the country.
Gamifying global health innovation
GHTC held a Game changers in global health game night on Capitol Hill to educate Congressional staffers about the impact of US leadership in global health research and development (R&D). Our guests ate, drank, played games, and learned how US investments in global health R&D not only saves lives around the world, but also generates benefits here at home in the United States. Here are some of our favorite photos.
Research Roundup: SFOPs funding for FY19, Lassa fever outbreak in West Africa, and new TB drug may shorten treatment time
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
A year in review: The global health innovation stories that shaped 2018
Two thousand eighteen was a turbulent year in global health. Between reemerging crises, breakthrough scientific discoveries, and the continued looming threat of health research funding cuts, 2018 took us on a roller coaster ride of peril and promise. Now as the year comes to an end, GHTC is taking a moment to reflect on the global health innovation stories and news that shaped 2018.
Trump signs spending bill boosting funding for health research
President Trump signed into law a spending bill that pairs full-year fiscal year (FY) 2019 funding for Labor, Health and Human Services (LHHS) and Defense with a stopgap measure to keep other agencies funded through December—staving off a partial government shutdown on the eve of the end of the fiscal year. Here’s a breakdown of how global health and medical research funding fared.
Global health and medical research saved from the chopping block in 2018 spending bill
What global health R&D advocates need to know about the 2018 omnibus spending bill.
Five issues to watch in US global health R&D policy in 2018
2018 is shaping up to be another important year for US policy related to global health and medical research. As Congress returns for a busy work session and the White House continues to roll out policy reforms, here are the top five issues GHTC will be following in 2018.

7 ways CDC is keeping us safe from deadly diseases
The threat is real: defunding the US Centers for Disease Control and Prevention (CDC) puts us all in danger, in every country of the globe.
Medical research, global health programs face steep cuts in Trump budget
On Tuesday, the Trump Administration released its full fiscal year 2018 budget proposal. This budget proposes significant cuts to programs that support global health and medical research at the National Institutes of Health, Centers for Disease Control and Prevention, and the US Agency for International Development.
Trump budget proposes steep cuts to research and foreign assistance that will threaten global health research
What global health advocates need to know about the President's "skinny" budget.
Research Roundup: Update on Zika R&D
In this regular feature on Breakthroughs, we highlight the most promising Zika virus vaccine, drug, and diagnostic candidates as well as vector control approaches.
Research Roundup: Priority Review Voucher legislation, Toxic Shock Syndrome vaccine, and repurposing existing drugs
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
365 review: Top global health innovation news of 2015
As 2015 draws to a close, the Global Health Technologies Coalition is reflecting on the past year in global health innovation.
Research Roundup: kid-friendly malaria medicine, Zika fever, priority review vouchers, and more
After four successful Phase 3 clinical trials enrolling more than 3,500 patients in 18 countries, the European Medicines Agency (EMA) has granted Pyramax® Granules, a pediatric malaria medicine, a positive opinion under Article 58—a mechanism through which the EMA reviews and issues a scientific opinion on products that are not intended for use in Europe.
Research Roundup: Congressional priorities, new HIV antibody, biomedical research funding, TB drug trial results, and more
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Research Roundup: Drug-resistant malaria, MDGs, World Breastfeeding Week, LHHS appropriations, and more
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.